Immunosuppressive Tumor Microenvironment of Osteosarcoma

Aaron Michael Taylor1, Jianting Sheng2, Patrick Kwok Shing Ng1

  • 1The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.

Cancers
|July 12, 2025
PubMed

Insights

Osteosarcoma research reveals an immunosuppressive tumor microenvironment. Key interactions involve myeloid-derived suppressor cells and regulatory T cells, hindering effective therapies for this pediatric bone cancer.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Osteosarcoma is the most common pediatric bone cancer.
  • It exhibits high genomic instability but lacks defining mutations.
  • Current therapies have shown limited improvement over 40 years.

Purpose of the Study:

  • To investigate the immune microenvironment of osteosarcoma.
  • To identify cellular subtypes and their interactions.
  • To understand mechanisms contributing to treatment resistance.

Main Methods:

  • Single-cell RNA sequencing of 12 osteosarcoma samples.
  • Spatial transcriptomics for subtype validation and spatial context.
  • Cell-cell communication modeling.

Main Results:

  • Identification of immunosuppressive cells: myeloid-derived suppressor cells (MDSCs), regulatory T cells, exhausted T cells, and LAMP3+ dendritic cells.
  • MDSCs interact with other cells, upregulating NF-κB and creating an immunosuppressive environment.
  • Regulatory T cells and osteosarcoma cells interact to promote tumor progression and angiogenesis.

Conclusions:

  • Osteosarcoma possesses a complex, immunosuppressive immune microenvironment.
  • Interactions involving MDSCs and regulatory T cells are critical drivers of tumor progression.
  • Targeting these cellular interactions may offer novel therapeutic strategies for osteosarcoma.

Related Concept Videos